1 / 10

David L. Day Director

David L. Day Director. UF Patents & Licensing. Impact of UF Tech-Based Start-up Companies 2003. Direct impact : sales, jobs and income generated by the companies

naasir
Télécharger la présentation

David L. Day Director

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. David L. Day Director

  2. UF Patents & Licensing

  3. Impact of UF Tech-Based Start-up Companies 2003 • Direct impact: sales, jobs and income generated by the companies • Indirect impact: economic activity generated by businesses selling goods and services because of the presence of the UF-connected companies • Induced impact: economic activity generated from spending by employees of those companies

  4. Start-ups are often the most appropriate (only) vehicle to bridge the technology gap And Gap Funds are often the only way to get the Start-up Started! Bridging the Technology Gap Science Products

  5. Innovation R&D Hotbeds MIT, Caltech – And the Gators? How the University of Florida moved to the Major league of technology startups BusinessWeek - May 21, 2007

  6. Regeneration Technologies, Inc. is a UF spin-off that processes donated human tissue into allograft implants • Has distributed over 800,000 implants with zero incidence of infection • In many cases enabling patients to walk again

  7. Orthopaedics & Sports Medicine Institute Genetics/Cancer Research Institute (opened in February 2005) (opened in Spring 2006) * Each building received $30 million from successful IPO of RTIX * “The RTIX Effect”

  8. AxoGen products will support peripheral nerve repair and regeneration Company was formed in 2003 To date AxoGen has raised approximately $10 million

  9. David L. Day Director

More Related